<SEC-DOCUMENT>0001088875-25-000018.txt : 20250212
<SEC-HEADER>0001088875-25-000018.hdr.sgml : 20250212
<ACCEPTANCE-DATETIME>20250212092613
ACCESSION NUMBER:		0001088875-25-000018
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250212
DATE AS OF CHANGE:		20250212

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEOGEN CORP
		CENTRAL INDEX KEY:			0000711377
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				382367843
		STATE OF INCORPORATION:			MI
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-40503
		FILM NUMBER:		25612502

	BUSINESS ADDRESS:	
		STREET 1:		620 LESHER PLACE
		CITY:			LANSING
		STATE:			MI
		ZIP:			48912
		BUSINESS PHONE:		5173729200

	MAIL ADDRESS:	
		STREET 1:		620 LESHER PLACE
		CITY:			LANSING
		STATE:			MI
		ZIP:			48912

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BAILLIE GIFFORD & CO
		CENTRAL INDEX KEY:			0001088875
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		CALTON SQUARE
		STREET 2:		1 GREENSIDE ROW
		CITY:			EDINBURGH
		STATE:			X0
		ZIP:			EH13AN
		BUSINESS PHONE:		00441312752000

	MAIL ADDRESS:	
		STREET 1:		CALTON SQUARE
		STREET 2:		1 GREENSIDE ROW
		CITY:			EDINBURGH
		STATE:			X0
		ZIP:			EH13AN
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001088875-24-000102</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001088875</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0000711377</issuerCik>
        <issuerName>NEOGEN CORP</issuerName>
        <issuerCusip>640491106</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>620 LESHER PLACE</com:street1>
          <com:street2>620 LESHER PLACE</com:street2>
          <com:city>LANSING</com:city>
          <com:stateOrCountry>MI</com:stateOrCountry>
          <com:zipCode>48912</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>BAILLIE GIFFORD &amp; CO</reportingPersonName>
      <citizenshipOrOrganization>X0</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>7578047.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>9749003.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>9749003.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>4.5</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>NEOGEN CORP</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>620 LESHER PLACE, 620 LESHER PLACE, LANSING, MICHIGAN, 48912.</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Baillie Gifford &amp; Co</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Calton Square
1 Greenside Row
Edinburgh
EH1 3AN
Scotland
UK</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Scotland</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>FI</typeOfPersonFiling>
        <otherTypeOfPersonFiling>Investment Adviser</otherTypeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>9,749,003</amountBeneficiallyOwned>
        <classPercent>4.50</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>7,578,047</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0.00</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>9,749,003</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0.00</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ? 240.14a-11.

By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to Investment Adviser is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>BAILLIE GIFFORD &amp; CO</reportingPersonName>
      <signatureDetails>
        <signature>Grant Meikle</signature>
        <title>Threshold &amp; Transaction Reporting Manager</title>
        <date>02/05/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
